People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Great Elm Capital Group, Inc. | — | Other | Series B | $30.0M | $498.4M | 2020 |
| SC Allergy Holdings, LLC | — | Other | Series B | $25.0M | $415.4M | 2018 |
| Source PTI HoldCo, LLC | — | Other | Seed | $1.2M | $21.7M | 2016 |
| Source M&M Holdings, LLC | — | Other | Pre-Seed | $640K | $14.8M | 2018 |
Thomas S. Harbin, III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas S. Harbin, III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin S. Emmons | 2 | 4 |
| Katherine G. Harbin | 2 | 2 |
| Matthew A Drapkin | 1 | 3 |
| Adam M. Kleinman | 1 | 2 |
| Jeffrey S Serota | 1 | 1 |
| Peter A Reed | 1 | 1 |
| Brent J Pearson | 1 | 1 |
| James P Parmelee | 1 | 1 |
| Mark A Snell | 1 | 1 |
| Jason M Reese | 1 | 1 |
| Eric A Scheyer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.